Anogenital cancers testing in Vigevano

Find health labs to test for Anogenital cancers in Vigevano and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Synlab

Via Roma, 8, 20086 Motta Visconti MI, Italia

6.7 km

Unverified

See Details

Pap Smear by Synlab

Via Filippo Binaschi, 1, 20082 Binasco MI, Italia

11.7 km

Unverified

See Details

Pap Smear by Synlab

Via Lombardia, 57, 20084 Lacchiarella MI, Italia

13.5 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via della Libertà, 4 20011 Corbetta (MI)

14.8 km

Unverified

See Details

Pap Smear by Synlab

Via Antonio Bianchi, 30, 20019 Settimo Milanese MI, Italia

14.8 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via I Maggio, 1A 20010 Vanzago (MI)

16 km

Unverified

See Details

Pap Smear by Synlab

Via dei Pini, 30, 20072 Pieve Emanuele MI, Italia

16.7 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Monsignor Paleari, 90 20010 Pogliano Milanese (MI)

16.5 km

Unverified

See Details

Pap Smear by Synlab

Via Gaspare Cavallini, 3, 27100 Pavia PV, Italia

17.2 km

Unverified

See Details

Pap Smear by Synlab

Corso Europa, 123, 20017 Rho MI, Italia

17 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.